Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Revance Therapeutics, Inc. (RVNC)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
03/31/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/23/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/23/2023
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/24/2022
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2022
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/24/2021
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/24/2021
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/11/2021
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/26/2020
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/26/2020
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/25/2019
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/20/2018
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/24/2017
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/18/2016
DEF 14A
Form DEF 14A - Other definitive proxy statements
03/26/2015
DEF 14A
Form DEF 14A - Other definitive proxy statements
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy